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Abstract
A 68-year-old white female presented with two years of progressively worsening dyspnea. Echocardiography
revealed a large right atrial mass and partial obstruction of the inferior vena cava. Further imaging revealed a cystic
dense mass in the inferior vena cava and right atrium. Immunohistochemical stains were consistent with leiomyo-
sarcoma. Intraoperatively, the tumor was noted to originate from the posterior aspect of the inferior vena cava. The
patient underwent successful resection of the mass. Adjuvant radiation therapy was completed. The patient’s dys-
pnea gradually improved and she continues to remain disease free five years post-resection.
Introduction
Leiomyosarcomas of vascular origin are rare tumors
arising most frequently from the inferior vena cava
(IVC). Only about 200 cases worldwide have been
reported since 1871 [1]. Leiomyosarcomas arising in the
IVC are most frequently seen in the sixth decade, with a
female predominance [2]. Symptoms are nonspecific and
may precede the diagnosis by several years [3]. Diagno-
sis is often challenging as patients may present with
non-specific complaints such as dyspnea, malaise, weight
loss, abdominal pain, or back pain [3]. Computed tomo-
graphy (CT), magnetic resonance imaging (MRI), indivi-
dually or in combination with cavography, ultrasound
(US), and echocardiography, allow an early and accurate
preoperative diagnosis [3]. We describe an unusual case
of a leiomyosarcoma of the IVC and review the
literature.
Case presentation
Our patient is a 68-year-old white female with a two-
year history of progressive dyspnea and a persistent
non-productive cough. Past medical history included
hypertension, lower extremity neuropathy of unknown
etiology, and interstitial cystitis. She had a remote his-
tory of tobacco use but no exposures to other toxins.
Family history was positive for stroke, diabetes, coronary
artery disease, and gastric cancer. Physical exam was
normal except for bilateral trace lower extremity edema.
No jugular venous distension, heart murmur, or tumor
plop was present.
Four months previously, a CT scan of the chest, pul-
monary function tests, and a pulmonary angiogram were
normal. A sleep study showed no apnea but nocturnal
hypoxia prompting a prescription for home O2 at night.
At the time of re-evaluation, a transthoracic echocar-
diogram (TTE) demonstrated a normal ejection fraction
of 60% with normal chamber dimensions but showed a
large right atrial mass with high flow velocity around
the echodensity. A small patent foramen ovale (PFO)
was also present. Estimated pulmonary artery pressure
was 44 mmHg. A transesophageal echocardiogram con-
firmed the large immobile right atrial mass, which
involved the IVC. A CT scan revealed a cystic dense
mass in the IVC and the right atrium with no evidence
of pulmonary emboli or metastases (Figure 1). The
abdomen and pelvis were negative with no evidence of
renal cell carcinoma, which can also present with IVC
involvement.
There was mild cerebral atrophy without evidence of
intracranial masses on a CT scan of the head. A com-
bined PET (positron emission tomography)/CT scan of
the chest showed a partially contrast-enhancing intra-
luminal mass within the intrahepatic and suprahepatic
inferior vena cava extending into the right atrium.
There was no extension into the hepatic veins. The
mass markedly narrowed the suprahepatic inferior vena
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cava and right atrium with only a small amount of resi-
dual lumen noted medially. There was diffuse heteroge-
neity of the liver without evidence of mass lesion,
suggesting hepatic venous congestion. The PET imaging
demonstrated uptake in the tumor mass consistent with
malignancy but no evidence of metastatic disease. Mag-
netic resonance angiography (MRA/MRI) showed that
the large mass centered at the confluence of the inferior
vena cava and right atrium and extended into the right
atrium (Figure 2). The mass extended 2.5 cm below the
diaphragm. The widest transverse dimension was 4.5 cm
and the greatest length obliquely was 5.6 cm. There was
collateral venous flow with dilatation of the azygous
vein and lumbar collaterals.
A fluoroscopically guided biopsy was preformed and
histology revealed spindle shaped cells. Immunostains
for smooth muscle actin and desmin were positive and
those for melanoma and cytokeratin were negative, con-
sistent with the diagnosis of leiomyosarcoma (Figure 3).
Intraoperatively, the tumor was noted to originate
from the posterior aspect of the IVC and measured
approximately 8 cm in length by 4 cm in width, with
the widest part lying within the right atrium. Ten min-
utes of circulatory arrest was required and the tumor
was excised along with a portion of the posterior infer-
ior vena cava. The tumor mass was well demarcated
with gross total resection. Of note, tumor margins at
the time of resection were negative. The inferior vena
cava was then closed primarily from the intraluminal
side. Surgical clips were left in place to help identify the
target for radiation therapy. In addition, the patient had
her PFO surgically corrected. The patient tolerated the
procedure well and was weaned from bypass without
difficulty.
Postoperatively, the patient received radiation therapy.
The patient received a course targeting the resection
bed of the origin of her tumor in the inferior vena cava.
She was treated with photons of 18 megavolts (MV) at
the isocenter at 2 Gray (Gy) per fraction for 25 fractions
to a total dose of 50 Gy. This was followed by an addi-
tional boost to a small area for an additional five frac-
tions to a total dose 10 Gy. The total dose to the tumor
bed was 60 Gy. The patient tolerated the course of
radiation well and reported no side effects, such as skin
toxicity or gastrointestinal toxicity. There were no
breaks during treatment.
Subsequent clinical examinations every 6 months and
imaging with yearly CT scans have confirmed that the
patient has remained disease free 5 years after
treatment.
Discussion
Tumors such as renal carcinomas, pheochromocytomas,
hematomas or testicular tumors can secondarily invade
Figure 1 CT Abdomen showing leiomyosarcoma in the inferior vena cava. On the left (a), note that the transverse diameter of the mass is
approximately 4.5 cm. On the right (b), the tumor mass is seen clearly within the right atrium.
Figure 2 MRA/MRI of the mass in the inferior vena cava. On the left (a), MRA highlighting the tumor mass in the inferior vena cava. On the
right (b), MRI highlighting the tumor mass in the inferior vena cava.
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the vena cava. Leiomyosarcomas of the inferior vena
cava are primary vascular tumors that are relatively rare
[1]. They are most frequently seen in the sixth decade
with a female predominance [2]. Metastatic disease can
involve the liver, lung, lymph nodes, or bone. However,
metastases have been reported in fewer than 50% of
cases [4].
Clinical findings are nonspecific and may precede the
diagnosis by several years [3]. Initial symptoms are often
relatively minor. The three most common presenting
symptoms are abdominal pain (52%), distention (20%),
and deep venous thrombosis (12%) [5]. Other findings
include the Budd-Chiari syndrome, a new heart mur-
mur, signs of cerebral embolism, and pain in the abdo-
men and/or the back.
In 1992 the International Registry of Inferior Vena
Cava Leiomyosarcomas collected 218 cases [1]. In that
series, tumors arose from the IVC lower segment in 80
patients, from the middle in 94, and from the upper
IVC in 41 [1]. IVC leiomyosarcomas arising below the
renal vein (segment I) cause pain in the right-lower
quadrant, back, and flank as well as causing varying
degrees of lower extremity edema [4]. Those arising in
the middle caval segment (segment II) cause right-
upper-quadrant pain and sometimes renovascular
hypertension [4]. Those arising above the hepatic vein
(segment III) cause varying manifestations of the Budd-
Chiari syndrome [4].
Modern imaging modalities using computed tomogra-
phy, magnetic resonance imaging, individually or in
combination with cavography, ultrasound, and echocar-
diography, allow for an early and accurate preoperative
diagnosis, resulting in a higher rate of surgical resection
and improved survival [2,3,5]. It is also speculated that
the recent progress of diagnostic investigations, such as
spiral CT with reconstruction and, positron emission
tomography (PET), will be able to even further define
tumor extent and aid in defining the most appropriate
treatment approach [6]. In the present case, the PET
scan showed mild abnormal glucose consumption com-
patible with a malignancy such as sarcoma and repre-
sents the first reported case of leiomyosarcoma of the
IVC imaged by PET/CT.
Despite advancing imaging technology, a biopsy is still
indicated for formal diagnosis. Histopathology of leio-
myosarcoma reveals spindle tumor cells, which are posi-
tive for markers of smooth muscle activity including
vimentin, muscle actin, alpha-smooth muscle actin, and
desmin [7].
Because of limited experience with this disease, the
optimal management of IVC leiomyosarcoma is
unknown [8]. Aggressive surgical treatment is recom-
mended in light of the tumor’s slow growth pattern and
relatively low metastatic potential [4]. There is limited
experience in the literature regarding surgical manage-
ment of these IVC tumors and limited data on the
long-term survival of these patients. Complete surgical
resection with a tumor-free margin (1 cm) is felt to be
the treatment of choice [2]. A case series of 25 patients
with primary IVC leiomyosarcoma treated between
1982 and 2002 showed that complete resection of pri-
mary IVC leiomyosarcomas was feasible and that the
IVC could be managed either by primary repair or liga-
tion with a low risk of severe postoperative edema [5].
Resection of the IVC with prosthetic reconstruction
allows for complete tumor resection and provides dur-
able relief from symptoms of venous obstruction [8].
Tumors involving the lower IVC are most amenable to
surgery while upper caval leiomyosarcomas are the least
amenable to complete removal. Extensive collateral
venous drainage of the left kidney preserves renal func-
tion during resection of middle caval tumors [4].
Figure 3 Histology and immunohistochemistry of leiomyosarcoma of the IVC. H&E (a, ×200) stain showing spindle cells. Tumor is positive
for desmin (b, ×200, brown) indicating smooth muscle lineage consistent with leiomyosarcoma.
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Neoadjuvant therapy may be given to downsize the
tumor and increase resectability rates. Nonetheless,
when complete resection is not possible, debulking com-
bined with radiation therapy still provides good pallia-
tion [2]. In another series, 14 patients with
leiomyosarcoma of the IVC were treated wide resection
between 1978 and 1997; in this series, radiation therapy
diminished local recurrence and improved median survi-
val (6 months in 2 patients without irradiation com-
pared to 51 months in 12 irradiated patients) [9].
Patients who received combined chemotherapy and
radiation lived longer than those who received radiation
therapy alone (P < 0.05) [9]. Chemotherapy, using adria-
mycin-ifosfamide or chemotherapy combined with
radiation therapy offer potential adjuvant treatment
options [10]. The 5-year cumulative survival rate was
53% for patients with leiomyosarcoma of the IVC sug-
gesting that aggressive surgical management combined
with adjuvant therapy offers the best treatment for
patients with leiomyosarcoma of the IVC [9].
The International Registry of Inferior Vena Cava (IVC)
Leiomyosarcomas analyzed their cohort of patients for
predictive factors of clinical outcome. A radical tumor
resection was undertaken in 134 (61.5%) patients, 26
(11.9%) had a palliative resection, and 58 (26.6%) were
inoperable [1]. An increased risk of death was associated
with upper IVC segment involvement (p < 0.001), lower
limb edema (p < 0.001), Budd-Chiari syndrome (p <
0.001), intraluminal tumor growth (p < 0.001) and IVC
occlusion (p < 0.001) [1]. Radical tumor resection was
associated with better 5- and 10-year survival rates
(49.4% and 29.5%) when compared to patients under-
going palliative resection or those who were inoperable
[1]. Data published in 2003 showed that patients under-
going complete resection had 3- and 5-year survival
rates of 76% and 33% respectively [5]. Tumors that
arose from the middle segment fared better than those
of the lower segment (p < 0.002) in one case series [1].
The absence of a palpable abdominal mass (p < 0.03) or
abdominal pain (p < 0.04) was also associated with a
better outcome and longer survival [1]. Another case
review of 14 patients found that age, gender, tumor size,
tumor grade, and lymph node status did not impact sur-
vival of patients with leiomyosarcoma of the IVC [9].
In these patients, overall prognosis remains poor with
a mean survival of 2 years but ranging from a few weeks
to eight years [4]. Even in this population, the risks and
benefits of palliative resection must still be considered
as significant symptomatic relief has been reported.
Conclusion
Leiomyosarcomas are the most common malignancy
involving the IVC. Although correlations between clini-
cal manifestations and the location of the tumor within
the IVC have been noted, patients often present with
non-specific symptoms such as dyspnea, malaise, weight
loss, and abdominal or back pain. Fluoroscopically
guided biopsy is required for diagnosis, but various ima-
ging modalities have allowed for earlier diagnosis and,
subsequently, better outcomes. A combined PET/CT
scan can be used for staging and to assist with treat-
ment planning. Though chemotherapy and/or radiation
therapy may serve as adjuncts to surgical resection,
aggressive surgical treatment is currently recommended
due to the tumor’s slow growth pattern and low meta-
static potential.
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